Membrane palmitoylated protein MPP1 inhibits immune escape by regulating the USP12/ CCL5 axis in urothelial carcinoma DOI
Qiang Lü, Jiancheng Lv,

X. Li

и другие.

International Immunopharmacology, Год журнала: 2024, Номер 146, С. 113802 - 113802

Опубликована: Дек. 18, 2024

Язык: Английский

Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer DOI Creative Commons
Jun Liu, Jiaye Lu,

Ling Wu

и другие.

Journal of Advanced Research, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

The incidence of skin cancer is currently increasing, and conventional treatment options inadequately address the demands disease management. Fortunately, recent rapid advancement immunotherapy, particularly immune checkpoint inhibitors (ICIs), has ushered in a new era for numerous patients. However, efficacy immunotherapy remains suboptimal due to impact tumor microenvironment (TME). Tumor-associated macrophages (TAMs), major component TME, play crucial roles invasion, metastasis, angiogenesis, evasion, significantly impacting development. Consequently, TAMs have gained considerable attention years, their been extensively studied various tumors. specific regulatory mechanisms remain unclear. This paper aims elucidate origin classification TAMs, investigate interactions between cells, comprehensively understand precise by which contribute pathogenesis different types cancer, finally discuss current strategies targeting cancer. With emphasis on interrelationship this posits that therapeutic modalities centered hold promise augmenting harmonizing with prevailing clinical interventions thereby charting novel trajectory advancing landscape immunotherapeutic approaches

Язык: Английский

Процитировано

7

Pseudostellaria heterophylla (Miq.) Pax, a Traditional Folk Medicine, Ameliorates Colorectal Cancer by Remodeling the Tumor Immune Microenvironment DOI
Gui Yang, Hui Wu, Heng Fan

и другие.

Journal of Ethnopharmacology, Год журнала: 2025, Номер 342, С. 119362 - 119362

Опубликована: Янв. 17, 2025

Язык: Английский

Процитировано

1

Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment DOI
Lu Liu, Yafei Li, Bo Li

и другие.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Год журнала: 2025, Номер unknown, С. 189344 - 189344

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

1

The myokine CCL5 recruits subcutaneous preadipocytes and promotes intramuscular fat deposition in obese mice DOI

Wensai Yu,

Yao Yao,

Nanwei Ye

и другие.

AJP Cell Physiology, Год журнала: 2024, Номер 326(5), С. C1320 - C1333

Опубликована: Март 18, 2024

Intramuscular fat (IMF) refers to the lipid stored in skeletal muscle tissue. The number and size of intramuscular adipocytes are primary factors that regulate IMF content. can be derived from either situ or ectopic migration. In this study, it was discovered regulation levels is achieved through chemokine (C-C motif) ligand 5 (CCL5)/chemokine receptor (CCR5) pathway by modulating adipocyte coculture experiments, C2C12 myotubes were more effective promoting migration 3T3-L1 preadipocytes than myoblasts, along with increasing CCL5. Correspondingly, overexpressing CCR5, one receptors CCL5, facilitated their Conversely, application CCL5/CCR5 inhibitor, MARAVIROC (MVC), reduced vivo, transplanted experiments subcutaneous adipose tissue (SCAT) transgenic mice expressing green fluorescent protein (GFP) provided evidence injecting recombinant CCL5 (rCCL5) into promotes muscle. level increased obesity. Blocking axis MVC inhibited deposition, whereas elevated promoted deposition obese mice. These results establish a link between pathway, which could have potential for

Язык: Английский

Процитировано

4

Integrin β8 Facilitates Macrophage Infiltration and Polarization by Regulating CCL5 to Promote LUAD Progression DOI Creative Commons
Lei Song, Yu Xi, Yang Wu

и другие.

Advanced Science, Год журнала: 2024, Номер 12(2)

Опубликована: Ноя. 13, 2024

Abstract The tumor microenvironment (TME) influences cancer progression and metastasis. Integrin β 8 (ITG 8), a member of the integrin family, is upregulated in various cancers. In this study, it determined as key factor that mediates interaction between lung adenocarcinoma (LUAD) cells macrophages. Increased expression levels ITG are associated with increased numbers CD163+ macrophages poor prognosis LUAD patients. overexpression promotes polarization THP‐1 toward M2 phenotype. contrast, TCM (conditioned medium from co‐culture system) 8‐overexpressing A549 promoted proliferation invasion cells. Mechanistically, chemokine (C‐C motif) ligand 5 (CCL5) plays an important role mediating 8‐induced macrophage polarization, phosphoinositide 3‐kinase (PI3K)/AKT serine/threonine kinase (AKT)/interferon regulatory 9 (IRF9) pathway involved process. Moreover, interleukin (IL8) 10 (IL10) produced by M2‐like regulate through spi‐1 proto‐oncogene (SPI1). This study elucidates feedback mechanism

Язык: Английский

Процитировано

4

Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma DOI

Huantong Wu,

Xinqiang Li,

Boyan Zhang

и другие.

British Journal of Cancer, Год журнала: 2024, Номер 130(10), С. 1609 - 1620

Опубликована: Апрель 11, 2024

Язык: Английский

Процитировано

3

Immune microenvironment and immunotherapy for chordoma DOI Creative Commons
Yujia Chen, Hongwei Zhang

Frontiers in Oncology, Год журнала: 2024, Номер 14

Опубликована: Июнь 24, 2024

Chordoma, as a rare, low-grade malignant tumor that tends to occur in the midline of body, grows slowly but often severely invades surrounding tissues and bones. Due severe invasion damage tissues, chordoma is difficult be gross totally resected surgery, progression residual unavoidable. Besides, insensitive conventional radiotherapy chemotherapy, thus finding effective treatment methods for urgent. Nowadays, immunotherapy has made series breakthroughs shown good therapeutic effects kinds tumors, which brings new insights into tumors without strategies. With deepening research on immunotherapy, some studies focused immune microenvironment have been published, most them concentrated infiltration cells, expression tumor-specific antigen or checkpoint expression. On this basis, are under way, encouraging results. In review, we reviewed about chordoma, combined with existing clinical trials data, hoping clarify frontiers limitations research, provide reference follow-up chordoma.

Язык: Английский

Процитировано

3

Systemic Trafficking of Macrophages in Implant Wear Debris-Induced Periprosthetic Osteolysis DOI Creative Commons

Mengyun Lou

SLAS TECHNOLOGY, Год журнала: 2025, Номер unknown, С. 100254 - 100254

Опубликована: Фев. 1, 2025

Periprosthetic osteolysis (PPOL) is a significant complication post-joint replacement, often instigated by implant wear debris, leading to chronic inflammation and bone resorption. Herein, this review summarizes the immune mechanisms of PPOL, specifically, processes where macrophages are recruited which trigger inflammatory cascades, role chemokines that facilitate macrophage migration, including CCL2, CCL3, CCL4, CCL5, CXCL8, CX3CL1, XCL1. This highlights novel findings on these suggests illustrating offers promising avenues for future therapeutic strategies prevent treat such as potential use anti-inflammatory drugs.

Язык: Английский

Процитировано

0

The immune response of upper and lower airway epithelial cells to Aspergillus fumigatus and Candida albicans-derived β-glucan in Th17 type cytokine environment DOI

Murat Turkbey,

Dilara Karagüzel, Ali Doruk Uzunkaya

и другие.

Archives of Microbiology, Год журнала: 2025, Номер 207(4)

Опубликована: Фев. 24, 2025

Язык: Английский

Процитировано

0

A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors DOI Creative Commons
Dequan Liu, Lei Liu, Xinming Zhao

и другие.

Critical Reviews in Oncology/Hematology, Год журнала: 2025, Номер 210, С. 104702 - 104702

Опубликована: Март 22, 2025

Although immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, primary resistance and acquired continue to limit their efficacy for many patients. To address enhance the anti-tumor activity within tumor microenvironment (TIME), numerous therapeutic strategies targeting both innate adaptive cells emerged. These include combination therapies with ICIs, chimeric antigen receptor T-cell (CAR-T), macrophages (CAR-Ms) or natural killer cell (CAR-NK) therapy, colony stimulating factor 1 (CSF1R) inhibitors, dendritic (DC) vaccines, toll-like (TLR) agonists, cytokine therapies, chemokine inhibition. approaches underscore significant potential of TIME in treatment. This article provides a comprehensive up-to-date review mechanisms action various TIME, as well each type, aiming deepen understanding potential.

Язык: Английский

Процитировано

0